$9.60 -0.03 (-0.31%)
11/6/2009 4:00 PM

Electro-Optical Sciences, Inc. (MELA)

CAPS Rating: 4 out of 5

A medical device company which focuses on designing and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma.

Current Price $9.60 Mkt Cap $192.83M
Open $9.63 P/E Ratio 0.00
Prev. Close $9.63 Div. (Yield) N/A (N/A)
Daily Range $9.43 - $9.73 Volume 420,442
52-Wk Range $2.29 - $11.73 Avg. Daily Vol. 430,000

MELA News and Commentary

Caps

How do you think MELA will perform vs the S&P 500?

Add Stock to Watchlist

All Members

160 Outperform
8 Underperform
 

All-Star Members

46 Outperform
3 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top MELA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TSIF (98.51)
Submitted October 26, 2009

Electro-Optical Sciences has a trade ticker that says more about what the company does than the company name does. Mela, (short for Melanoma) has designed a tool to determine if melanoma spots are cancerous or not that has a 98% accuracy rate,… More

0 Comments | Reply | Report this Post

TMFDitty (99.09)
Submitted May 17, 2008

Total R&D shop, and headed for the fate of so many of its ilk. EOS has a nice cash stash, don't get me wrong -- but it's burning through it at a prodigious rate, and has no revenue whatsoever to offset the cash burn. I figure 18 months, tops,… More

0 Comments | Reply | Report this Post
MELA VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about MELA.

Recs

0
Member Avatar cashsage (60.05) Submitted: 11/5/2009 11:51:37 AM : Underperform Start Price: $10.05 MELA Score: +5.44

MELA has a too high valuation compared to its sales potential. It is also loss making at least until 2011.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar at8man (< 20) Submitted: 10/28/2009 9:56:25 AM : Outperform Start Price: $10.63 MELA Score: -10.98

Once approval is granted from the FDA on the Mela Find device every dermatologist in the world will be scrambling to buy one. MELA can only go up.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar IsleGirl2010 (93.85) Submitted: 10/27/2009 6:30:32 PM : Outperform Start Price: $11.00 MELA Score: -13.65

Great tool to have. I'm sure it'll catch on soon.

Report this Post 0 Comments | Reply | Permalink
View All 36 Pitches »

Leaderboard

Find the members with the highest scoring picks in MELA.

Score Leader

caslonsvcs

caslonsvcs (88.66) Score: +79.69

The Score Leader is the member with the highest score across all their picks in MELA.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
caslonsvcs 88.66 8/25/2008 8/31/2009 Outperform 3M $5.80 +65.52% -14.18% +79.69
stockblog 91.26 9/29/2008 Outperform 1Y $5.61 +71.12% -7.78% +78.90
wccjimh 52.61 9/15/2008 Outperform 1Y $6.30 +52.38% -9.26% +61.64
steevil01 < 20 9/19/2008 Outperform 5Y $6.58 +45.90% -13.63% +59.52
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. kikr 93.29 5/16/2008 5/12/2009 Outperform 3Y $7.15 +34.27% -22.19% +56.46
BuffaloKite < 20 5/16/2008 Outperform 1Y $7.15 +34.27% -22.19% +56.46
tlavender 21.31 5/16/2008 Outperform 3Y $7.15 +34.27% -22.19% +56.46
Mrpayo < 20 7/28/2008 Outperform NS $6.66 +44.14% -11.92% +56.07
dollarfreefall < 20 7/21/2008 Outperform NS $6.71 +43.07% -12.12% +55.19
keidoandkevin 62.43 8/27/2008 Outperform 3M $6.83 +40.56% -14.10% +54.65
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackOppenheimer 26.63 8/19/2009 Outperform NS $7.49 +28.17% +9.25% +18.92
TrackJesupLamont < 20 5/13/2008 Outperform NS $7.15 +34.27% -20.87% +55.13

Featured Broker Partners